- Home
- AAME vs ASRT Comparison
AAME vs ASRT Comparison
Compare AAME & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAME
- ASRT
- Stock Information
- Founded
- AAME 1968
- ASRT 1995
- Country
- AAME United States
- ASRT United States
- Employees
- AAME N/A
- ASRT N/A
- Industry
- AAME Life Insurance
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- AAME Finance
- ASRT Health Care
- Exchange
- AAME Nasdaq
- ASRT Nasdaq
- Market Cap
- AAME 68.4M
- ASRT 79.1M
- IPO Year
- AAME N/A
- ASRT 1997
- Fundamental
- Price
- AAME $3.44
- ASRT $0.95
- Analyst Decision
- AAME
- ASRT Strong Buy
- Analyst Count
- AAME 0
- ASRT 1
- Target Price
- AAME N/A
- ASRT $3.00
- AVG Volume (30 Days)
- AAME 38.7K
- ASRT 222.4K
- Earning Date
- AAME 11-11-2025
- ASRT 11-10-2025
- Dividend Yield
- AAME 0.59%
- ASRT N/A
- EPS Growth
- AAME N/A
- ASRT N/A
- EPS
- AAME 0.10
- ASRT N/A
- Revenue
- AAME $198,977,000.00
- ASRT $117,099,000.00
- Revenue This Year
- AAME N/A
- ASRT N/A
- Revenue Next Year
- AAME N/A
- ASRT $5.84
- P/E Ratio
- AAME $32.42
- ASRT N/A
- Revenue Growth
- AAME 6.98
- ASRT N/A
- 52 Week Low
- AAME $1.25
- ASRT $0.51
- 52 Week High
- AAME $3.71
- ASRT $1.38
- Technical
- Relative Strength Index (RSI)
- AAME 66.93
- ASRT 76.35
- Support Level
- AAME $3.20
- ASRT $0.79
- Resistance Level
- AAME $3.35
- ASRT $0.83
- Average True Range (ATR)
- AAME 0.20
- ASRT 0.04
- MACD
- AAME -0.03
- ASRT 0.01
- Stochastic Oscillator
- AAME 86.67
- ASRT 88.81
About AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.